initial cohort of 184 TIDM patients and 361 controls, and confirmed our data in a second cohort of 513 patients and 857 controls. In both cohorts, +1239C carriers displayed a significantly higher risk of TIDM than +1239A homozygotes (combined cohorts: OR=1.63, 95%CI: 1.34-1.97). Clinical analysis did not detect any differences between patients carrying or not +1239C in terms of gender distribution and age at TIDM diagnosis. These data suggest that SPPI variants marked by +1239C are associated with TIDM development in the Italian population. The predisposing effect may depend on its effect on Opn levels. Type 1 diabetes (TlDM) is the result of selective destruction of the insulin-producing beta-cells by autoimmune aggression, mainly driven by pro-inflammatory type 1 T helper cells (THl) and cytotoxic T lymphocytes (CTL) (1) (2) . Its development seems to involve environmental factors acting on a predisposing genetic background (3) (4) . The most important gene involved in TlDM susceptibility maps in the human MHC locus has a strong association with the HLA-DR3 and/or -DR4 antigens (5) . However, non-MHC loci are also involved and may account for more than 50% of the genetic susceptibility (6) (7) (8) .
Secreted phosphoprotein 1, also known as Osteopontin (Opn), is a cytokine expressed by many immune cells, including macrophages, T cells and NK cells. It is involved in the inflammatory and immune responses by activating macrophages and enhancing the THI cell response (9) (10) (11) (12) (13) . We previously showed high Opn serum levels in patients with autoimmune lymphoproliferative syndrome (ALPS), multiple sclerosis (MS), and systemic lupus erythematosus (SLE) (14) (15) (16) . Sequencing of the Opn gene (SPP1), mapping at 4q2l-q25, detected two single nucleotide polymorphisms (SNPs) displaying associations with these diseases, namely +1239A/C (rs9138) in the 3'UTR and-l 56G/GG (rs76873 16) in the 5'flanking region. Carriers of + l239C displayed higher risk of developing ALPS (8-fold higher), MS (1.5-fold), and SLE (1.5-fold) than + l239A homozygotes (14) (15) (16) . Moreover, +1239C mRNA was more stable than + l239A mRNA, and healthy +l239C carriers displayed about 2-fold higher serum levels of Opn than + l239A homozygotes. The -156G allele was associated with SLE only (16) .
An Opn role in TlDM has been suggested by detection of a striking up-regulation of Opn in the early phases preceding the diabetes onset in the islets and pancreatic lymph nodes of non-obese diabetic (NOD) mice. In humans, some of us recently typed -156G/GG and a second SNP in the SPPI promoter (-66T/G) (rs28357094) in Italian TlDM patients and detected a significant association with the -66G allele (17) , whereas no association was found with -156G/GG. Since that study did not analyze the 3'UTR region, the aim of this work is to extend the analysis of Italian TlDM patients to this region by typing +1239A/C.
MATERIALSAND METHODS
Patients and randomly selected, ethnically matched, healthy controls were enrolled from the Diabetes Centers of five main hospitals in north western Italy: the Maggiore Hospital of Novara (Novara, Italy), the San Giovanni Battista Hospital of Turin and the Regina Margherita Children Hospital of Turin (Turin, Italy), IRCCS Policlinico S. Matteo (Pavia, Italy), and Giannina Gaslini Children's Hospital (Genoa, Italy). Patients were consecutive Caucasian Italian patients followed by the Diabetes Centers of Novara (n=97), Turin (n=358), Pavia (n=69), and Genoa (n=173); controls were consecutive Italian donors obtained from the transfusion services of the respective hospitals. Patients and controls were unrelated and Italian. Overlaps between different sites were ruled out.
We typed the +1239A/C SNP in 2 independent cohorts of consecutive patients and controls. The first cohort consisted of 184 patients and 361 controls, the second of 513 patients and 857 controls. All subjects gave their informed consent according to the Declaration of Helsinki (International Committee of Medical Journal Editors, 1995). The research was approved by the local ethics committee.
DNA analysis
Genomic DNA was isolated from PBMC using standard methods. Primers used to sequence the 3'UTR were Opn-for (5'-GCCGTGAATTCCACAGCC-3') and Opn-rev (5'-GCTCTACACCACCAAATTCTT ATTACATTCAAG-3 '). For amplification, 200 ng of genomic DNA were used as template and PCR products were purified with the EXO/SAP kit (GE Healthcare, Piscataway, NJ, USA). Sequencing was performed with the ABI PRISMR BigDyeTM Terminator kit (Applied Biosystems, Foster City, CA, USA) on an automatic sequencer (Applied Biosystems 3100 Genetic Analyser) according to the manufacturer's instructions with the amplification primers. In the second cohort, genotyping of +1239A/C SNP was performed with the TaqMan 5' allelic discrimination assay (Applied Biosystems). Allelic specific primers and fluorogenic probes were used for discrimination (ASSAY ID C_8826997, Cod.4351376, Applied Biosystems). Genotyping of each sample was automatically attributed by the SDS 1.3 software for allelic discrimination.
HLA-DQAI and DQBI genomic typing
HLA-DQAl and DQBl genes were typed at high resolution level using the reverse PCR-SSO technique, as previously described (18), in 92 patients (39 AA subjects and 53 non-AA subjects) and 677 healthy children recruited from the cord blood bank of the Pavia center. The controls were ethnically matched with the patients and checked for absence of diabetes in their families.
Statistical analysis
Genotype distributions were analyzed with the chi square (X 2 ) test. All p values are 2-tailed and the significance cut-off was p<0.05.
RESULTS
We typed + l239A/C in an initial cohort of 184 TlDM patients and 361 ethnically-and geographically-matched controls by sequencing genomic DNA (Fig. lA) . Results showed that frequency of + l239C was significantly higher in TlDM patients than in controls (39% vs 29%, p=0.0005); analysis of the genotypic distribution showed that + l239C carriers (heterozygotes and homozygotes), displayed a significantly higher risk of TlDM than +1239A homozygotes (OR=1.90, CI 1.30-2.78, p=0.00074) (Table I) .
To confirm these results, + l239A/C was typed in a second cohort of 513 patients and 857 controls by TaqMan 5' allelic discrimination assay (Fig. lB) . Here, too, frequency of + l239C was significantly higher in patients than in controls (34% vs 28%, p=0.00035), and + 1239C carriers displayed higher risk ofTlDM than +1239Ahomozygotes (OR=1.54, 1.23-1.94, p=O.OOO 15) ( analysis, susceptible heterodimers were those comprising a DQa chain with an arginine at position 52 and a DQP chain with a non-aspartic acid at position 57; a subject can have 1, 2 or 4 susceptible heterodimers, the higher the number, the higher the risk ofT 1DM (19) . Results showed that, as expected, the overall distribution of subjects carrying 0, 1, 2, or 4 susceptible heterodimers was significantly different in the patients and the controls, but it was similar in the patients carrying or not carrying +1239C (Table  II) . Moreover, the proportion of subjects carrying 4 predisposing heterodimers was significantly higher in the patients than in the controls (62% vs 1.6%, p<10-5 ) , but it was similar in the patients carrying or not carrying +1239C (63.3% vs 61.5%, p=0.88). These data suggests that the predisposing role of these HLA alleles is similar in these patient groups.
DISCUSSION
This work stems from our previous observation that the +1239C SNP of SPPI is associated with production of increased amounts of Opn and favors development ofALPS, MS and SLE, and shows that it also predisposes to TlDM. This is suggested by the finding that frequency of +1239C carriers was higher in two independent cohorts of TlDM patients than in the respective controls; in the combined cohorts of697 TlDM patients and 1218 controls, this allele conferred an OR=1.63 for TlDM development (CI: 1.34-1.97 p=0.0000005). Moreover, HLA typing of a small group ofpatients suggests that this variation did not influence the role played by HLA predisposing alleles, whose frequency was similarly increased in patients carrying or not +1239C.
The effect of +1239C on TlDM development may be related to its effect on Opn production, since it is associated with a high "baseline" production that may be due to the higher stability of its mRNA than the +1239A mRNA, as we previously showed in transfected cells (14) (15) ). An alternative possibility is that +1239C does not have a direct effect, but is in LD with other variations. Indeed, SPP1 lies in a long LD block (126kb) and, according to HapMap (http:// www.hapmap.org/) and literature, 18 validated SNPs (with minor allele frequency >0.05) are located in the SPP 1 genomic region. The +1239 SNP shows a perfect LD with two SPP1 synonymous variations in the coding region (+282T/C, rs4754; +750C/T, rs1l226616), and a high LD (r 2;::::0.7) with another 3'UTR SNP (+1083A/G, rsI126772), and 10 other markers located in the SPP1 3' flanking region or in intronic sequences of the other gene contained in the SPPI LD block (PKD2, Polycystic Kidney Disease 2). Moreover, it is in significant LD (D'=0.9, r 2=0.15, p<0.05) with the -66T/G SNP (16) recently found to be associated with TlDM in the Italian population (17) . Therefore, further studies are needed to define the primarily associated variation.
Recent genome-wide association studies (GWAS) reported no association with TlDM for markers in the SPPI region in large cohorts from Canada, US, and UK (20) (21) . Although the +1239 SNP was not included in these studies, SNPs in LD (r 2;::::0.6) with +1239 were included in both studies and they did not display association. In particular, the synonymous +282T/C (rs4754) variation, that is in high LD (r 2=0.94 in HapMap CEU data, r 2=1.0 in our samples) with the +1239 SNP, showed no association (p>0.05) in about 1,000 patients from Canada (C Polychronakos, personal communication). This inconsistency might be explained by a population-specific association of SPPI in TlDM. Several causes might explain a population-specific association of SNPs in complex diseases (22) . For instance, the association detection may be favored by the peculiar allelic frequencies of the SNPs or by their LD with untyped causal alleles in that population. A substantial influence may also be exerted by interactions with populationspecific environmental exposures or unlinked genetic factors. Classical population genetic studies highlighted the genetic distances of the Italian and other Mediterranean populations from northern European populations (23). Since the GWAS so far reported for TlDM have been performed in populations mainly of northern European origin, it is likely that other associations will emerge from studies of different populations.
In conclusion, this work detects an SPP1 variation that is clearly associated with TlDM development in the Italian population. The predisposing effect may depend on Opn-mediated support of inflammation and THI cell differentiation, which may build up an autoimmune-prone background favoring development of the autoimmune aggression of beta cells.
